BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 28860740)

  • 1. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.
    Song JH; Lee CH; Kim JW; Lee WY; Jung JY; Park JH; Jung KS; Yoo KH; Park YB; Kim DK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2455-2464. PubMed ID: 28860740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
    Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts.
    Cheng SL; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2341-2348. PubMed ID: 27703344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy.
    Benson VS; Pascoe KC; Siddall J; Small M; Müllerová H
    Int J Chron Obstruct Pulmon Dis; 2019; 14():2711-2723. PubMed ID: 31819403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of asthma-COPD overlap syndrome.
    Joo H; Han D; Lee JH; Rhee CK
    Int J Chron Obstruct Pulmon Dis; 2017; 12():697-703. PubMed ID: 28260876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids.
    Siddiqui SH; Pavord ID; Barnes NC; Guasconi A; Lettis S; Pascoe S; Petruzzelli S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3669-3676. PubMed ID: 30464449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey.
    Ding B; Small M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1753-1763. PubMed ID: 28670116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between Fractional Exhaled Nitric Oxide Level and Efficacy of Inhaled Corticosteroid in Asthma-COPD Overlap Syndrome Patients with Different Disease Severity.
    Feng JX; Lin Y; Lin J; He SS; Chen MF; Wu XM; Xu YZ
    J Korean Med Sci; 2017 Mar; 32(3):439-447. PubMed ID: 28145647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.
    Landis S; Suruki R; Maskell J; Bonar K; Hilton E; Compton C
    COPD; 2018 Apr; 15(2):177-184. PubMed ID: 29558236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled corticosteroids, blood eosinophils, and FEV
    Whittaker HR; Müllerova H; Jarvis D; Barnes NC; Jones PW; Compton CH; Kiddle SJ; Quint JK
    Int J Chron Obstruct Pulmon Dis; 2019; 14():1063-1073. PubMed ID: 31213788
    [No Abstract]   [Full Text] [Related]  

  • 11. The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS).
    Albertson TE; Chenoweth JA; Pearson SJ; Murin S
    Expert Opin Pharmacother; 2020 Feb; 21(2):213-231. PubMed ID: 31955671
    [No Abstract]   [Full Text] [Related]  

  • 12. The distribution of blood eosinophil levels in a Japanese COPD clinical trial database and in the rest of the world.
    Barnes N; Ishii T; Hizawa N; Midwinter D; James M; Hilton E; Jones PW
    Int J Chron Obstruct Pulmon Dis; 2018; 13():433-440. PubMed ID: 29440882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort.
    Hastie AT; Martinez FJ; Curtis JL; Doerschuk CM; Hansel NN; Christenson S; Putcha N; Ortega VE; Li X; Barr RG; Carretta EE; Couper DJ; Cooper CB; Hoffman EA; Kanner RE; Kleerup E; O'Neal WK; Paine R; Peters SP; Alexis NE; Woodruff PG; Han MK; Meyers DA; Bleecker ER;
    Lancet Respir Med; 2017 Dec; 5(12):956-967. PubMed ID: 29146301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma.
    Kitaguchi Y; Komatsu Y; Fujimoto K; Hanaoka M; Kubo K
    Int J Chron Obstruct Pulmon Dis; 2012; 7():283-9. PubMed ID: 22589579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Belgian survey on the diagnosis of asthma-COPD overlap syndrome.
    Cataldo D; Corhay JL; Derom E; Louis R; Marchand E; Michils A; Ninane V; Peché R; Pilette C; Vincken W; Janssens W
    Int J Chron Obstruct Pulmon Dis; 2017; 12():601-613. PubMed ID: 28243078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Which bronchodilator reversibility criteria can predict severe acute exacerbation in chronic obstructive pulmonary disease patients?
    Kim J; Kim WJ; Lee CH; Lee SH; Lee MG; Shin KC; Yoo KH; Lee JH; Lim SY; Na JO; Hwang HG; Hong Y; Lim MN; Yoo CG; Jung KS; Lee SD
    Respir Res; 2017 May; 18(1):107. PubMed ID: 28558829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness to inhaled corticosteroid treatment in patients with asthma-chronic obstructive pulmonary disease overlap syndrome.
    Lim HS; Choi SM; Lee J; Park YS; Lee SM; Yim JJ; Yoo CG; Kim YW; Han SK; Lee CH
    Ann Allergy Asthma Immunol; 2014 Dec; 113(6):652-7. PubMed ID: 25280465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical burden of illness among patients with severe eosinophilic COPD.
    Müllerová H; Meeraus WH; Galkin DV; Albers FC; Landis SH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():741-755. PubMed ID: 31114180
    [No Abstract]   [Full Text] [Related]  

  • 20. Blood Eosinophil Counts, Withdrawal of Inhaled Corticosteroids and Risk of COPD Exacerbations and Mortality in the Clinical Practice Research Datalink (CPRD).
    Oshagbemi OA; Franssen FME; van Kraaij S; Braeken DCW; Wouters EFM; Maitland-van der Zee AH; Driessen JHM; de Vries F
    COPD; 2019 Apr; 16(2):152-159. PubMed ID: 31117850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.